Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Japanese Journal of Clinical Oncology|October 6, 2016
Role of multimodality therapy in cIIIA-N2 non-small cell lung cancer: perspectiveHidehito Horinouchi
Translational Lung Cancer Research|March 10, 2016
Anti-vascular endothelial growth factor therapies at the crossroads: linifanib for non-small cell lung cancerHidehito Horinouchi
Expert Opinion on Biological Therapy|October 18, 2016
The prospect of patritumab for treating non-small cell lung cancerHidehito Horinouchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 26, 2025
[MRD Testing in Lung Cancer-Latest Insights and Developments]Takahiro Karasaki, Hidehito Horinouchi
Japanese Journal of Clinical Oncology|March 3, 2020
History of Japan Clinical Oncology Group (JCOG) Lung Cancer Study GroupHidehito Horinouchi, Yuichiro Ohe
Japanese Journal of Clinical Oncology|June 6, 2023
Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistanceTaisuke Araki, Shintaro Kanda, Hidehito Horinouchi, et al.
Japanese Journal of Clinical Oncology|August 17, 2022
Medical management of older patients with lung cancerYoshitaka Zenke, Taiki Hakozaki, Yoshiro Nakahara, et al.
Lung Cancer (Amsterdam, Netherlands)|March 24, 2015
Immunohistochemical status of PD-L1 in thymoma and thymic carcinomaYuki Katsuya, Yu Fujita, Hidehito Horinouchi, et al.
Japanese Journal of Clinical Oncology|December 20, 2024
Real-world treatment patterns and survival in extensive stage small-cell lung cancer in JapanHidehito Horinouchi, Chia-Hsien Suzu Chang, Jaime Shaw, et al.
The Journal of Medical Investigation : JMI|September 18, 2008
Gemcitabine plus UFT combination chemotherapy as second- or third-line therapy in non-small cell lung cancer: a pilot studyNaoki Nishimura, Rika Sugiura, Hirotaka Ueda, et al.
Pageof 22